Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1

Oncogene

Volumn 30, Issue 4, 2011, Pages 482-493

  Sengupta, S ^a   Mantha, A K ^a   Mitra, S ^a,b   Bhakat, K K ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

acetylation; APE1; MDR1; RNA pol II; YB 1 p300

Indexed keywords

CISPLATIN; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; ETOPOSIDE; LUCIFERASE; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN P300; REDOX EFFECTOR FACTOR 1; RNA POLYMERASE II; Y BOX BINDING PROTEIN 1;

ACETYLATION; ARTICLE; CANCER RESISTANCE; CELL STRAIN HEK293; COMPLEX FORMATION; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; WILD TYPE;

ACETYLATION; BLOTTING, WESTERN; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P-GLYCOPROTEIN; P300-CBP TRANSCRIPTION FACTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA POLYMERASE II; TRANSFECTION;

EID: 79251647522     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.435     Document Type: Article

References (73)

1. Ahmad S, Glazer RI. (1993). Expression of the antisense cDNA for protein kinase C alpha attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells. Mol Pharmacol 43: 858-862.
2. Ahmad S, Safa AR, Glazer RI. (1994). Modulation of P-glycoprotein by protein kinase C alpha in a baculovirus expression system. Biochemistry 33: 10313-10318.
3. Ambudkar SV, Sauna ZE, Gottesman MM, Szakacs G. (2005). A novel way to spread drug resistance in tumor cells: functional intercellular transfer of P-glycoprotein (ABCB1). Trends Pharmacol Sci 26: 385-387.
4. Ando K, Hirao S, Kabe Y, Ogura Y, Sato I, Yamaguchi Y et al. (2008). A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity. Nucleic Acids Res 36: 4327-4336.
5. Bapat A, Fishel M, Kelley MR. (2009). Going Ape as an approach to cancer therapeutics. Antioxid Redox Signal 11: 651-668.
6. Bargou RC, Jurchott K, Wagener C, Bergmann S, Metzner S, Bommert K et al. (1997). Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med 3: 447-450.
7. Bhakat KK, Izumi T, Yang SH, Hazra TK, Mitra S. (2003a). Role of acetylated human AP-endonuclease (APE1/Ref-1) in regulation of the parathyroid hormone gene. EMBO J 22: 6299-6309.
8. Bhakat KK, Mantha AK, Mitra S. (2009). Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein. Antioxid Redox Signal 11: 621-638.
9. Bhakat KK, Mitra S. (2000). Regulation of the human O(6)- methylguanine-DNA methyltransferase gene by transcriptional coactivators cAMP response element-binding protein-binding protein and p300. J Biol Chem 275: 34197-34204.
10. Bhakat KK, Mokkapati SK, Boldogh I, Hazra TK, Mitra S. (2006). Acetylation of human 8-oxoguanine-DNA glycosylase by p300 and its role in 8-oxoguanine repair in vivo. Mol Cell Biol 26: 1654-1665.
11. Bhakat KK, Yang SH, Mitra S. (2003b). Acetylation of human APendonuclease 1, a critical enzyme in DNA repair and transcription regulation. Methods Enzymol 371: 292-300.
12. Bhattacharyya A, Chattopadhyay R, Burnette BR, Cross JV, Mitra S, Ernst PB et al. (2009). Acetylation of apurinic/apyrimidinic endonuclease- 1 regulates Helicobacter pylori-mediated gastric epithelial cell apoptosis. Gastroenterology 136: 2258-2269.
13. Blobel GA. (2000). CREB-binding protein and p300: molecular integrators of hematopoietic transcription. Blood 95: 745-755.
14. Bobola MS, Finn LS, Ellenbogen RG, Geyer JR, Berger MS, Braga JM et al. (2005). Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors. Clin Cancer Res 11: 7405-7414.
15. Busso CS, Iwakuma T, Izumi T. (2009). Ubiquitination of mammalian AP endonuclease (APE1) regulated by the p53-MDM2 signaling pathway. Oncogene 28: 1616-1625.
16. Chattopadhyay R, Das S, Maiti AK, Boldogh I, Xie J, Hazra TK et al. (2008). Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1. Mol Cell Biol 28: 7066-7080.
17. Chaudhary PM, Roninson IB. (1993). Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst 85: 632-639.
18. Cho H, Orphanides G, Sun X, Yang XJ, Ogryzko V, Lees E et al. (1998). A human RNA polymerase II complex containing factors that modify chromatin structure. Mol Cell Biol 18: 5355-5363.
19. Curtis CD, Thorngren DL, Ziegler YS, Sarkeshik A, Yates JR, Nardulli AM. (2009). Apurinic/apyrimidinic endonuclease 1 alters estrogen receptor activity and estrogen-responsive gene expression. Mol Endocrinol 23: 1346-1359.
20. Das S, Chattopadhyay R, Bhakat KK, Boldogh I, Kohno K, Prasad R et al. (2007). Stimulation of NEIL2-mediated oxidized base excision repair via YB-1 interaction during oxidative stress. J Biol Chem 282: 28474-28484.
21. Demple B, Harrison L. (1994). Repair of oxidative damage to DNA: enzymology and biology. Annu Rev Biochem 63: 915-948.
22. Doetsch PW, Cunningham RP. (1990). The enzymology of apurinic/ apyrimidinic endonucleases. Mutat Res 236: 173-201.
23. Evans AR, Limp-Foster M, Kelley MR. (2000). Going APE over ref-1. Mutat Res 461: 83-108.
24. Fan J, Wilson III DM. (2005). Protein-protein interactions and posttranslational modifications in mammalian base excision repair. Free Radic Biol Med 38: 1121-1138.
25. Fantini D, Vascotto C, Deganuto M, Bivi N, Gustincich S, Marcon G et al. (2008). APE1/Ref-1 regulates PTEN expression mediated by Egr-1. Free Radic Res 42: 20-29.
26. Fishel ML, Kelley MR. (2007). The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. Mol Aspects Med 28: 375-395.
27. Fuchs S, Philippe J, Corvol P, Pinet F. (2003). Implication of Ref-1 in the repression of renin gene transcription by intracellular calcium. J Hypertens 21: 327-335.
28. Germann UA, Chambers TC. (1998). Molecular analysis of the multidrug transporter, P-glycoprotein. Cytotechnology 27: 31-60.
29. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A et al. (1989). Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81: 116-124.
30. Gottesman MM, Fojo T, Bates SE. (2002). Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2: 48-58.
31. Gottesman MM, Pastan I. (1993). Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427.
32. Higashi K, Inagaki Y, Fujimori K, Nakao A, Kaneko H, Nakatsuka I. (2003). Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3. J Biol Chem 278: 43470-43479.
33. Izumi T, Brown DB, Naidu CV, Bhakat KK, Macinnes MA, Saito H et al. (2005). Two essential but distinct functions of the mammalian abasic endonuclease. Proc Natl Acad Sci USA 102: 5739-5743.
34. Izumi T, Wiederhold LR, Roy G, Roy R, Jaiswal A, Bhakat KK et al. (2003). Mammalian DNA base excision repair proteins: their interactions and role in repair of oxidative DNA damage. Toxicology 193: 43-65.
35. Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S, Prives C. (1997). Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev 11: 558-570.
36. Jiang Y, Guo C, Vasko MR, Kelley MR. (2008). Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons. Cancer Res 68: 6425-6434.
37. Jin S, Scotto KW. (1998). Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol Cell Biol 18: 4377-4384.
38. Kaina B, Christmann M. (2002). DNA repair in resistance to alkylating anticancer drugs. Int J Clin Pharmacol Ther 40: 354-367.
39. Kaina B, Ochs K, Grosch S, Fritz G, Lips J, Tomicic M et al. (2001). BER, MGMT, and MMR in defense against alkylation-induced genotoxicity and apoptosis. Prog Nucleic Acid Res Mol Biol 68: 41-54.
40. Kelley MR, Cheng L, Foster R, Tritt R, Jiang J, Broshears J et al. (2001). Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin Cancer Res 7: 824-830.
41. Kohno K, Izumi H, Uchiumi T, Ashizuka M, Kuwano M. (2003). The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 25: 691-698.
42. Kohno K, Sato S, Takano H, Matsuo K, Kuwano M. (1989). The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem Biophys Res Commun 165: 1415-1421.
43. Kohno K, Tanimura H, Sato S, Nakayama Y, Makino Y, Wada M et al. (1994). Cellular control of human multidrug resistance 1 (MDR-1) gene expression in absence and presence of gene amplification in human cancer cells. J Biol Chem 269: 20503-20508. (Pubitemid 24260456)
44. Kovacic P. (2007). Unifying mechanism for anticancer agents involving electron transfer and oxidative stress: clinical implications. Med Hypotheses 69: 510-516.
45. Kovacic P, Osuna Jr JA. (2000). Mechanisms of anti-cancer agents: emphasis on oxidative stress and electron transfer. Curr Pharm Des 6: 277-309. (Pubitemid 30412684)
46. Kuninger DT, Izumi T, Papaconstantinou J, Mitra S. (2002). Human AP-endonuclease 1 and hnRNP-L interact with a nCaRE-like repressor element in the AP-endonuclease 1 promoter. Nucleic Acids Res 30: 823-829.
47. Loeb LA, Preston BD. (1986). Mutagenesis by apurinic/apyrimidinic sites. Annu Rev Genet 20: 201-230.
48. Mantha AK, Oezguen N, Bhakat KK, Izumi T, Braun W, Mitra S. (2008). Unusual role of a cysteine residue in substrate binding and activity of human AP-endonuclease 1. J Mol Biol 379: 28-37.
49. Matsumoto Y, Kim K. (1995). Excision of deoxyribose phosphate residues by DNA polymerase beta during DNA repair. Science 269: 699-702.
50. McNeill DR, Lam W, DeWeese TL, Cheng YC, Wilson III DM. (2009). Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites. Mol Cancer Res 7: 897-906.
51. Mitra S, Izumi T, Boldogh I, Bhakat KK, Hill JW, Hazra TK. (2002). Choreography of oxidative damage repair in mammalian genomes. Free Radic Biol Med 33: 15-28.
52. Mujtaba S, He Y, Zeng L, Farooq A, Carlson JE, Ott M et al. (2002). Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. Mol Cell 9: 575-586.
53. Neish AS, Anderson SF, Schlegel BP, Wei W, Parvin JD. (1998). Factors associated with the mammalian RNA polymerase II holoenzyme. Nucleic Acids Res 26: 847-853.
54. Okamura H, Yoshida K, Sasaki E, Morimoto H, Haneji T. (2004). Transcription factor NF-Y regulates mdr1 expression through binding to inverted CCAAT sequence in drug-resistant human squamous carcinoma cells. Int J Oncol 25: 1031-1037.
55. Okazaki T, Chung U, Nishishita T, Ebisu S, Usuda S, Mishiro S et al. (1994). A redox factor protein, ref1, is involved in negative gene regulation by extracellular calcium. J Biol Chem 269: 27855-27862.
56. Ordway JM, Eberhart D, Curran T. (2003). Cysteine 64 of Ref-1 is not essential for redox regulation of AP-1 DNA binding. Mol Cell Biol 23: 4257-4266.
57. Pajic M, Iyer JK, Kersbergen A, van der Burg E, Nygren AO, Jonkers J et al. (2009). Moderate increase in MDR1a/1b expression causes in vivo resistance to doxorubicin in a mouse model for hereditary breast cancer. Cancer Res 69: 6396-6404.
58. Rahman I. (2002). Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. Biochem Pharmacol 64: 935-942.
59. Ramana CV, Boldogh I, Izumi T, Mitra S. (1998). Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proc Natl Acad Sci USA 95: 5061-5066.
60. Robertson KA, Bullock HA, Xu Y, Tritt R, Zimmerman E, Ulbright TM et al. (2001). Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res 61: 2220-2225.
61. Robertson KA, Hill DP, Xu Y, Liu L, Van Epps S, Hockenbery DM et al. (1997). Down-regulation of apurinic/apyrimidinic endonuclease expression is associated with the induction of apoptosis in differentiating myeloid leukemia cells. Cell Growth Differ 8: 443-449.
62. Shen DW, Fojo A, Chin JE, Roninson IB, Richert N, Pastan I et al. (1986). Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science 232: 643-645.
63. Singhal RK, Prasad R, Wilson SH. (1995). DNA polymerase beta conducts the gap-filling step in uracil-initiated base excision repair in a bovine testis nuclear extract. J Biol Chem 270: 949-957.
64. Tell G, Quadrifoglio F, Tiribelli C, Kelley MR. (2009). The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal 11: 601-620.
65. Vascotto C, Cesaratto L, Zeef LA, Deganuto M, D'Ambrosio C, Scaloni A et al. (2009). Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. Proteomics 9: 1058-1074.
66. Walker LJ, Robson CN, Black E, Gillespie D, Hickson ID. (1993). Identification of residues in the human DNA repair enzyme HAP1 (Ref-1) that are essential for redox regulation of Jun DNA binding. Mol Cell Biol 13: 5370-5376.
67. Wang D, Luo M, Kelley MR. (2004). Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol Cancer Ther 3: 679-686.
68. Xanthoudakis S, Curran T. (1992). Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J 11: 653-665.
69. Xanthoudakis S, Miao G, Wang F, Pan YC, Curran T. (1992). Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J 11: 3323-3335.
70. Xu Y, Moore DH, Broshears J, Liu L, Wilson TM, Kelley MR. (1997). The apurinic/apyrimidinic endonuclease (APE/Ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer. Anticancer Res 17: 3713-3719.
71. Yamamori T, DeRicco J, Naqvi A, Hoffman TA, Mattagajasingh I, Kasuno K et al. (2010). SIRT1 deacetylates APE1 and regulates cellular base excision repair. Nucleic Acids Res 38: 832-845.
72. Yoshida M, Kijima M, Akita M, Beppu T. (1990). Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by Trichostatin A. J Biol Chem 265: 17174-17179.
73. Yu G, Ahmad S, Aquino A, Fairchild CR, Trepel JB, Ohno S et al. (1991). Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun 3: 181-189.